A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma
Clinical trial NCT04813354 · COMPLETED
Trial details
- NCT number
- NCT04813354
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2021-07-08
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.